PSMA radioligand therapy (PRLT) of metastatic castration-resistant prostate cancer: first results using the PSMA Inhibitor 617

被引：0
|
作者：
Kulkarni, Harshad [1 ]
Singh, Aviral [1 ]
Niepsch, Karin [1 ]
Schuchardt, Christiane [1 ]
Baum, Richard [1 ]
机构：
[1] Zent Klin Bad Berka, THERANOST Ctr Mol Radiotherapy & Mol Imaging PET, Bad Berka, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
139
引用
收藏
页数：2
相关论文
共 50 条
  • [31] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Khreish, Fadi
    Ebert, Niklas
    Ries, Martin
    Maus, Stephan
    Rosar, Florian
    Bohnenberger, Hendrik
    Stemler, Tobias
    Saar, Matthias
    Bartholomae, Mark
    Ezziddin, Samer
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (03) : 721 - 728
  • [32] 225Ac-PSMA-617/177Lu-PSMA-617 tandem therapy of metastatic castration-resistant prostate cancer: pilot experience
    Fadi Khreish
    Niklas Ebert
    Martin Ries
    Stephan Maus
    Florian Rosar
    Hendrik Bohnenberger
    Tobias Stemler
    Matthias Saar
    Mark Bartholomä
    Samer Ezziddin
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 721 - 728
  • [33] PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
    Kratochwil, Clemens
    Giesel, Frederik L.
    Stefanova, Melsa
    Benesova, Martina
    Bronzel, Marcus
    Afshar-Oromieh, Ali
    Mier, Walter
    Eder, Matthias
    Kopka, Klaus
    Haberkorn, Uwe
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (08) : 1170 - 1176
  • [34] Effectiveness of 177Lu PSMA-617 radioligand therapy in patients with metastatic castration resistant prostate cancer
    Gunalp, Bengul
    Emer, Mustafa
    Ozaydin, Sukru
    Alagoz, Engin
    Ince, Semra
    Ayan, Asli
    Alkan, Sumeyye
    Mahmudov, Sarkhan
    Okuyucu, Kursat
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [35] Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
    Prive, Bastiaan M.
    Slootbeek, Peter H. J.
    Laarhuis, Babette, I
    Naga, Samhita Pamidimarri
    van Der Doelen, Maarten J.
    van Kalmthout, Ludwike W. M.
    de Keizer, Bart
    Ezziddin, Samer
    Kratochwil, Clemens
    Morgenstern, Alfred
    Bruchertseifer, Frank
    Ligtenberg, Marjolijn J. L.
    Witjes, J. Alfred
    van Oort, Inge M.
    Gotthardt, Martin
    Heskamp, Sandra
    Janssen, Marcel J. R.
    Gerritsen, Winald R.
    Nagarajah, James
    Mehra, Niven
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (01) : 71 - 78
  • [36] Radioligand Therapy of metastatic Prostate Cancer with Lu-PSMA-617
    Manych, Matthias
    AKTUELLE UROLOGIE, 2017, 48 (05)
  • [37] Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Karimzadeh, Amir
    Lehnert, Wencke
    Koehler, Daniel
    Shenas, Farzad
    Kisters, Anna
    Apostolova, Ivayla
    Klutmann, Susanne
    Adam, Gerhard
    Sauer, Markus
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2025,
  • [38] Intermittent radioligand therapy with Lu-177-PSMA-617 in metastatic castration-resistant prostate cancer patients with favorable characteristics and early response
    Mader, N.
    Ngoc, C. Nguyen
    Baumgarten, J.
    Groener, D.
    Davis, K.
    Wichert, J.
    Tselis, N.
    Mandel, P.
    Gruenwald, F.
    Sabet, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S491 - S492
  • [39] Personalized dosimetry assessment of [177Lu]Lu-PSMA-617 radioligand therapy in the management of metastatic castration-resistant prostate cancer
    Kazemi-Jahromi, Mahmood
    Yazdani, Elmira
    Karamzade-Ziarati, Najme
    Asadi, Mahboobeh
    Sadeghi, Mahdi
    Geramifar, Parham
    INTERNATIONAL JOURNAL OF RADIATION BIOLOGY, 2024, 100 (11) : 1551 - 1559
  • [40] Impact of DNA damage repair defects on response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer
    Bastiaan M. Privé
    Peter H. J. Slootbeek
    Babette I. Laarhuis
    Samhita Pamidimarri Naga
    Maarten J. van der Doelen
    Ludwike W. M. van Kalmthout
    Bart de Keizer
    Samer Ezziddin
    Clemens Kratochwil
    Alfred Morgenstern
    Frank Bruchertseifer
    Marjolijn J. L. Ligtenberg
    J. Alfred Witjes
    Inge M. van Oort
    Martin Gotthardt
    Sandra Heskamp
    Marcel J. R. Janssen
    Winald R. Gerritsen
    James Nagarajah
    Niven Mehra
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 71 - 78
12345